Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function
Article in Expert Review of Clinical Immunology (November 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
Article in New England Journal of Medicine (October 2023)
Identification of factors associated with fear of hypoglycemia using the capability, opportunity, motivation and behavior model in people with type 2 diabetes mellitus: a cross-sectional study
Article in Acta Diabetologica (June 2023)